Protalix BioTherapeutics (PLX) Other Non-Current Assets (2010 - 2026)

Protalix BioTherapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $589000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 28.32% year-over-year to $589000.0; the TTM figure through Mar 2026 stood at $589000.0 (up 28.32% YoY), while the FY2025 annual figure was $578000.0, up 25.11% from the prior year.
• Other Non-Current Assets was $589000.0 for Q1 2026 at Protalix BioTherapeutics, up from $578000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.1 million in Q1 2022 to a low of $459000.0 in Q1 2025.
• Historically, Other Non-Current Assets has averaged $896000.0 across 5 years, with a median of $578000.0 in 2025.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets slumped 58.33% in 2023, then advanced 28.32% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $1.3 million in 2022, then sank by 58.33% to $528000.0 in 2023, then decreased by 12.5% to $462000.0 in 2024, then grew by 25.11% to $578000.0 in 2025, then advanced by 1.9% to $589000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $589000.0 (Q1 2026), $578000.0 (Q4 2025), and $549000.0 (Q3 2025), per Business Quant data.